| 英文名称 |
中文名称 |
CAS号 |
操作 |
| WM-1119 |
化合物WM-1119 |
2055397-28-7 |
详细
|
| LIT-001 |
化合物LIT-001 |
2245072-21-1 |
详细
|
| ML418 |
ML418 |
1928763-08-9 |
详细
|
| Pexmetinib |
PEXMETINIB |
945614-12-0 |
详细
|
| Takinib |
1111556-37-6 |
1111556-37-6 |
详细
|
| PF-06409577 |
PF-06409577 |
1467057-23-3 |
详细
|
| Lanraplenib (succinate) |
GS-9876 monosuccinate |
1800046-97-2 |
详细
|
| APS6-45 |
化合物APS6-45 |
2188236-41-9 |
详细
|
| PD-1/PD-L1-IN-NP19 |
化合物PD-1/PD-L1-IN-NP19 |
2377916-66-8 |
详细
|
| Thalidomide-NH-PEG1-C2-NH2 |
4-((2-(2-氨基乙氧基)乙基)氨基)-2-(2,6-二氧代-哌啶-3-基)异吲哚-1,3-二酮 |
2138439-12-8 |
详细
|
| PRX-08066 Maleic acid |
PRX-08066 |
866206-55-5 |
详细
|
| SR33805 |
SR 33805 |
121345-64-0 |
详细
|
| CP-640186 Hydrochloride |
盐酸CP-640186 |
591778-70-0 |
详细
|
| NVR 3-778 |
4-fluoro-3-((4-hydroxypiperidin-1-yl)sulfonyl)-N-(3,4,5-trifluorophenyl)benzamide |
1445790-55-5 |
详细
|
| HM43239 |
化合物HM43239 |
2569527-64-4 |
详细
|
| 873307-04-1 |
(E)-3-(3-chlorophenyl)-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]prop-2-enamide |
873307-04-1 |
详细
|
| JNJ-47965567 |
N-[[4-(4-PHENYLPIPERAZIN-1-YL)OXAN-4-YL]METHYL]-2-PHENYLSULFANYLPYRIDINE-3-CARBOXAMIDE |
1428327-31-4 |
详细
|
| SNS-314 Mesylate |
N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸盐 (1:1) |
1146618-41-8 |
详细
|
| PDD 00017273 |
1945950-21-9 |
1945950-21-9 |
详细
|
| JNJ-40411813 |
JNJ40411813 |
1127498-03-6 |
详细
|
| S18-000003 |
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl- |
2068119-11-7 |
详细
|
| DDD107498 succinate |
MMV121 |
1469439-71-1 |
详细
|
| DDD107498 Fumarate |
|
|
详细
|
| KL001 |
N-(3-(9H-咔唑-9-基)-2-羟基丙基)-N-(呋喃-2-基甲基)甲烷磺酰胺 |
309928-48-1 |
详细
|
| BCATcInhibitor2 |
5-chloro-N'-[2-(trifluoromethyl)phenyl]sulfonyl-1-benzofuran-2-carbohydrazide |
406191-34-2 |
详细
|
| LH846 |
LH-846 |
639052-78-1 |
详细
|
| Ah 6809 |
6-异丙氧基-9-氧代氧杂蒽-2-羧酸 |
33458-93-4 |
详细
|
| SBI-0640756 |
CS-2838 |
1821280-29-8 |
详细
|
| N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide |
N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide |
354126-20-8 |
详细
|
| BMS-1001 |
BMS-1001盐酸盐 |
2113650-04-5 |
详细
|
| Lanraplenib |
GS-9876 |
1800046-95-0 |
详细
|
| RU-302 |
RU-302 |
1182129-77-6 |
详细
|
| ML335 |
825658-06-8 |
825658-06-8 |
详细
|
| TCN201 |
TCN-201 |
852918-02-6 |
详细
|
| Eliprodil (SL-820715) |
依利罗地 |
119431-25-3 |
详细
|
| SKLB 610 |
SKLB610 |
1125780-41-7 |
详细
|
| Sunitinib |
N-(2-二乙胺基乙基)-5-(5-氟-2-氧代-1,2-二氢吲哚-3-基亚甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺 |
342641-94-5 |
详细
|
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
详细
|
| VU6015929 |
VU6015929 |
|
详细
|
| CID 1375606 |
CID-1375606 |
313493-80-0 |
详细
|
| ASP7663 |
ASP 7663;ASP-7663;ASP7663 |
1190217-35-6 |
详细
|
| 1630086-24-6 |
|
1630086-24-6 |
详细
|
| I3MT-3 |
4(3H)-Pyrimidinone, 6-methyl-2-[[2-(1-naphthalenyl)-2-oxoethyl]thio]- |
459420-09-8 |
详细
|
| NPD8733 |
化合物NPD8733 |
696655-62-6 |
详细
|
| AD57 |
化合物AD57 |
1093380-42-7 |
详细
|
| AD80 |
AD80 |
1384071-99-1 |
详细
|
| CVT-11127 |
N-[2-[6-[[(3,4-二氯苯基)甲基]氨基]-2-(4-甲氧基苯基)-3-氧代-3,4-二氢吡啶并[2,3-B]吡嗪-4-基]乙基]乙酰胺 |
1018674-83-3 |
详细
|
| AM095 sodium |
4'-[3-甲基-4-[[[(1R)-1-苯基乙氧基]羰基]氨基]-5-异恶唑基]联苯-4-乙酸钠盐 |
1345614-59-6 |
详细
|
| RS 25344 HCl |
1-(3-硝基苯基)-3-(吡啶-4-基甲基)吡啶并[2,3-D]嘧啶-2,4(1H,3H)-二酮盐酸盐 |
152815-28-6 |
详细
|
| CX-6258Hydrochloride |
CX-6258HCL |
1353859-00-3 |
详细
|
| VU 29 |
VU-29 |
890764-36-0 |
详细
|
| CDPPB |
3-氰基-N-(1,3-二苯基吡唑-5-基)苯甲酰胺 |
781652-57-1 |
详细
|
| N~2~-[(3,4-dimethoxyphenyl)sulfonyl]-N-(2,6-dimethylphenyl)-N~2~-(2-phenylethyl)glycinamide |
N~2~-[(3,4-dimethoxyphenyl)sulfonyl]-N-(2,6-dimethylphenyl)-N~2~-(2-phenylethyl)glycinamide |
439940-12-2 |
详细
|
| SEL201 |
2095704-43-9 |
2095704-43-9 |
详细
|
| ETC-159 |
1,2,3,6-四氢-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-哒嗪基)-7H-嘌呤-7-乙酰胺 |
1638250-96-0 |
详细
|
| BX 430 |
BX 430 |
688309-70-8 |
详细
|
| BMP signaling agonist sb4 |
SB 4 |
100874-08-6 |
详细
|
| Orelabrutinib |
奥布替尼 |
1655504-04-3 |
详细
|
| Ostarine (GTx-024) |
OSTARINE(MK-2866) |
841205-47-8 |
详细
|
| UT-34 |
UT-34 |
2168525-92-4 |
详细
|
| SJ000291942 |
SJ000291942 |
425613-09-8 |
详细
|
| GSK3787 |
GSK-3787 |
188591-46-0 |
详细
|
| SR9009 |
SR9009 |
1379686-30-2 |
详细
|
| CGP60474 |
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇 |
164658-13-3 |
详细
|
| UNC926 |
UNC-926 |
1184136-10-4 |
详细
|
| Insulin-like Growth Factor-1 Receptor Inhibitor |
胰岛素样生长因子-1 受体拮抗剂 |
468740-43-4 |
详细
|
| VUN65671 |
VUN65671 |
2479465-67-1 |
详细
|
| BI-605906 |
化合物 T14567 |
960293-88-3 |
详细
|
| T56-LIMKi |
T5601640 |
924473-59-6 |
详细
|
| PKC-iota inhibitor 1 |
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)烟酰胺 |
2328094-11-5 |
详细
|
| iGOT1-01 |
化合物IGOT1-01 |
882256-55-5 |
详细
|
| GOT1 inhibitor-1 |
N-(4-氯苯基)-4-(1H-吲哚-4-基)哌嗪-1-甲酰胺 |
732973-87-4 |
详细
|
| GJ-103 |
GJ103 游离 |
1459687-89-8 |
详细
|
| PZ-2891 |
PZ-2891 |
2170608-82-7 |
详细
|
| YF-2 |
YF-2 |
1311423-89-8 |
详细
|
| APS-2-79 |
2002381-25-9 |
2002381-25-9 |
详细
|
| ZUN97585,FGFR1/DDR2 inhibitor 1 |
FGFR1/DDR2 inhibitor 1 |
2308497-58-5 |
详细
|
| SRS11-92 |
化合物SRS11-92 |
1467047-25-1 |
详细
|
| GZD856 |
GZD856 |
1257628-64-0 |
详细
|
| JTZ-951 |
JTZ-951 |
1262132-81-9 |
详细
|
| WAY-262611 |
MAY-262611 |
1123231-07-1 |
详细
|
| TAK-615 |
化合物TAK-615 |
1664335-55-0 |
详细
|
| Oncrasin-1 |
1-(4-氯苄基)-1H-吲哚-3-甲醛 |
75629-57-1 |
详细
|
| RG3039 |
5-[[1-(2,6-二氯苄基)哌啶-4-基]甲氧基]喹唑啉-2,4-二胺 |
1005504-62-0 |
详细
|
| Wnt agonist 1 |
WNT AGONIST 1 (CID11210285 盐酸盐) |
853220-52-7 |
详细
|
| NITD-2 |
化合物NITD-2 |
1197896-79-9 |
详细
|
| (Rac)-IBT6A |
1412418-47-3 |
1412418-47-3 |
详细
|
| XL019 |
XL019 |
945755-56-6 |
详细
|
| Ro0711401 |
化合物RO0711401 |
714971-87-6 |
详细
|
| Evatanepag (CP-533536) |
2-[3-[N-(4-叔丁基苄基)-N-(吡啶-3-基磺酰基)氨基甲基]苯氧基]乙酸 |
223488-57-1 |
详细
|
| TCKHNS11 |
TC KHNS 11 |
1431540-99-6 |
详细
|
| SGC707 |
N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 |
1687736-54-4 |
详细
|
| SCH 546738 |
3-氨基-6-氯-5-[(3S)-4-[1-[(4-氯苯基)甲基]-4-哌啶基]-3-乙基-1-哌嗪基]-2-哌嗪甲酰胺 |
906805-42-3 |
详细
|
| APS-2-79 |
APS-2-79 盐酸盐 |
2002381-31-7 |
详细
|
| SC-236 |
4-(5-(4-氯苯基)-3-(三氟甲基)-1H- |
170569-86-5 |
详细
|
| FB23 |
FB23 |
2243736-35-6 |
详细
|
| PF-06446846 hydrochloride |
PF-06446846 |
1632250-50-0 |
详细
|
| BRD4770 |
2-苯甲酰胺基-1-(3-苯丙基)-1H-苯并[D]咪唑-5-羧酸甲酯 |
1374601-40-7 |
详细
|
| NCGC00378430 |
|
|
详细
|
| MS049 2HCl |
MS049 (hydrochloride) |
2095432-59-8 |
详细
|